Abstract:Abstract Background Curculigoside is a natural phenolic glycoside compound produced by Curculigo orchioides Gaertn. This study aimed to explore the effects of curculigoside in promoting the osteogenic differentiation of adipose-derived stem cells (ADSCs) as well as the underlying mechanism. Methods ADSCs were treated with curculigoside at different concentrations (0 μmol/L, 1 μmol/L, 2.5 μmol/L, 5 μmol/L, 10 μmol/L, and 20 μmol/L), and cell viability was assessed by CCK-8 assay. Then, the alkaline phosphatase (ALP) activity was determined, and alizarin red S (ARS) staining was performed to measure the extracellular mineralization of curculigoside. Information about protein-chemical interactions is provided by the search tool for interactions of chemicals (STITCH) database. Then, LY294002 was administered to explore the mechanism by which curculigoside promotes the osteogenic differentiation of ADSCs. Western blot assays were performed to assess changes in the expression of osteogenic-related markers and the phosphorylation of PI3K and AKT. Finally, we established an ovariectomized (OVX)-induced osteoporosis mouse model and administered curculigoside to explore the effects of curculigoside in preventing bone loss in vivo. Results The CCK-8 assay indicated that curculigoside did not induce cytotoxicity at a concentration of 5 μmol/L after 48 h. The ALP and ARS results revealed that the induced group had higher ALP activity and calcium deposition than the control group. Moreover, the curculigoside group exhibited increased biomineralization, ALP activity, and ARS staining compared to the induced and control groups, and these effects were partially inhibited by LY294002. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis indicated that the target genes of curculigoside were mainly involved in the PI3K-Akt signaling pathway. PCR and western blot analysis showed that the expression of RUNX2, ALP, and Osterix was upregulated in curculigoside-treated ADSCs, but this effect was partially reversed by the PI3K inhibitor LY294002. Moreover, the curculigoside-treated group exhibited significantly increased phosphorylation of AKT to P-AKT compared with the osteogenic induction group. After treatment with curculigoside, the mice had a higher bone volume than the OVX mice, suggesting partial protection from cancellous bone loss. In addition, when LY294002 was added, the protective effects of curculigoside could be neutralized. Conclusions Curculigoside could induce the osteogenic differentiation of ADSCs and prevent bone loss in an OVX model through the PI3K/Akt signaling pathway.

Curculigoside improves osteogenesis of human amniotic fluid-derived stem cells

Curculigoside Promotes Osteogenic Differentiation of Bone Marrow Stromal Cells from Ovariectomized Rats

Curculigoside promotes osteogenic differentiation of ADSCs to prevent ovariectomized-induced osteoporosis

Curculigoside Regulates Proliferation, Differentiation, and Pro-Inflammatory Cytokines Levels in Dexamethasone-Induced Rat Calvarial Osteoblasts.

Curculigoside Ameliorates Bone Loss by Influencing Mesenchymal Stem Cell Fate in Aging Mice

Curculigoside attenuates oxidative stress and osteoclastogenesis via modulating Nrf2/NF-κB signaling pathway in RAW264.7 cells

Curculigoside Inhibits the Progression of Osteoarthritis via Regulating Nucleotide-Binding Oligomerization Domain-Like Receptor Containing Pyrin Domain 3

Curculigo orchioides polysaccharide COP70-1 stimulates osteogenic differentiation of MC3T3-E1 cells by activating the BMP and Wnt signaling pathways

Curculigoside Protects against Titanium Particle-Induced Osteolysis through the Enhancement of Osteoblast Differentiation and Reduction of Osteoclast Formation

Metabolites of Curculigoside in Rats and Their Antiosteoporotic Activities in Osteoblastic Mc3t3-E1 Cells

Curculigoside Isolated from Curculigo Orchioides Prevents Hydrogen Peroxide-Induced Dysfunction and Oxidative Damage in Calvarial Osteoblasts

Curculigoside Protects against Excess-Iron-Induced Bone Loss by Attenuating Akt-FoxO1-Dependent Oxidative Damage to Mice and Osteoblastic MC3T3-E1 Cells

Curcumin Promotes Osteogenic Differentiation of Periodontal Ligament Stem Cells Through the PI3K/AKT/Nrf2 Signaling Pathway.

Effect of icariin and curculigoside on inhibition of osteoclastic formation,differentiation and bone absorption

Curcumin Promotes Osteogenic Differentiation of Human Periodontal Ligament Stem Cells by Inducting EGR1 Expression.

Antiosteoporotic activity of phenolic compounds from Curculigo orchioides

Effect of human umbilical cord mesenchymal stem cells on glucocorticoid-induced osteoporosis in rats through Wnt/β-catenin signaling pathway

Orcinol Glucoside Facilitates the Shift of MSC Fate to Osteoblast and Prevents Adipogenesis Via Wnt/β-catenin Signaling Pathway

Pharmacokinetic and Tissue Distribution Profile of Curculigoside after Oral and Intravenously Injection Administration in Rats by Liquid Chromatography-Mass Spectrometry.

Curculigoside Mitigates Hepatic Ischemia/reperfusion-Induced Oxidative Stress, Inflammation, and Apoptosis Via Activation of the Nrf-2/HO-1 Pathway.

Effect of curcumin on osteogenic differentiation of rat bone marrow mesenchymal stem cells